Analytical Epidemiology — MCQs
A study that examines individuals who have already contracted a disease to identify risk factors is called:
In the context of a cohort study, which of the following statistical measures is not typically used?
Berksonian bias is a type of ?
Which study design is best for rare diseases?
According to Hill's criteria, which of the following is NOT a criterion for establishing causality in noncommunicable diseases?
In which type of study is selection bias most likely to occur?
The difference between the incidence in the exposed and non-exposed group is best given by:
A 10-year long study concerning the use of fluorides and pit and fissure sealants in the control of caries on the same population group is an example of:
What is the primary purpose of interventional studies in clinical research?
What is the definition of Population Attributable Risk?
Analytical Epidemiology Indian Medical PG Practice Questions and MCQs
Question 1: A study that examines individuals who have already contracted a disease to identify risk factors is called:
- A. Control cohort
- B. Cohort
- C. Cross-sectional
- D. Case control (Correct Answer)
Explanation: ***Case control*** - A **case-control study** specifically examines individuals who have already contracted the disease (**cases**) and compares them to those without the disease (**controls**). - The **cases** component directly addresses studying people who have already developed the disease to identify **risk factors** and **exposures** that led to the condition. - This is a **retrospective study design** that works backward from disease to exposure. *Control cohort* - A control cohort refers to a group of individuals who **do not have the disease or exposure** of interest and serve as a comparison group. - This is a component of studies, not a study type itself. - This option focuses on **healthy or unexposed individuals**, not those who have already contracted the disease. *Cohort* - A **cohort study** follows a group of individuals over time to observe who develops disease (**prospective**) or examines past exposures and outcomes (**retrospective**). - While it may include diseased individuals, its primary focus is on **disease incidence** and **temporal relationships**, starting from exposure and moving forward to disease outcome. *Cross-sectional* - A **cross-sectional study** examines disease and exposure status **simultaneously** at a single point in time. - It provides a **snapshot** of prevalence but does not specifically focus on examining those who have already contracted disease to identify risk factors. - It cannot establish **temporal relationships** between exposure and disease.
Question 2: In the context of a cohort study, which of the following statistical measures is not typically used?
- A. Incidence rate
- B. Attributable risk percentage
- C. Relative risk
- D. Odds ratio (Correct Answer)
Explanation: ***Odds ratio*** - The **odds ratio** is primarily used in **case-control studies** to estimate the association between exposure and outcome. - While it can be calculated in a cohort study, it is not the most appropriate or typical measure of association, as the **relative risk** can be directly calculated. *Incidence rate* - **Incidence rate** is a measure reflecting the **rate at which new cases** of a disease or health condition occur in a population at risk over a specified period. - It is a fundamental measure in cohort studies to quantify the **risk of developing an outcome** in exposed versus unexposed groups. *Attributable risk percentage* - The **attributable risk percentage** quantifies the proportion of disease in the exposed group that is **attributable to the exposure**. - This measure helps determine the public health impact of an exposure in a cohort study. *Relative risk* - The **relative risk** (also called risk ratio) directly compares the incidence of disease in the exposed group to the incidence in the unexposed group. - It is the **primary measure of association** calculated in cohort studies, indicating how many times more likely an exposed group is to develop the outcome compared to an unexposed group.
Question 3: Berksonian bias is a type of ?
- A. Selection bias (Correct Answer)
- B. Information bias
- C. Interviewer bias
- D. Recall bias
Explanation: ***Selection bias*** - **Berkson's bias** is a form of **selection bias** that arises in studies conducted using hospital data. - It occurs when the probability of admission to a hospital or inclusion in a study is conditional on both exposure and disease status, leading to a **flawed association** between them. *Interviewer bias* - **Interviewer bias** is a type of **information bias** where the interviewer's expectations or knowledge about the study or participants influence the way information is sought or recorded. - This typically affects the **data collection process** and not the selection of participants. *Information bias* - **Information bias** is a broad category of biases that arise from **systematic errors in measurement** or classification of exposure or disease. - While Berkson's bias can lead to misinformation, its root cause is in how subjects are selected, not how data on those subjects is collected after selection. *Recall bias* - **Recall bias** is a type of **information bias** where there are systematic differences in the way participants **recall past events or exposures**. - It is particularly common in **case-control studies** where individuals with a disease may remember exposures differently than healthy controls.
Question 4: Which study design is best for rare diseases?
- A. Cross-sectional
- B. Cohort
- C. Case-control (Correct Answer)
- D. Randomized trial
Explanation: ***Case-control*** - This design is ideal for rare diseases because it starts by identifying individuals with the disease (cases) and then retrospectively compares their exposure to a potential risk factor with a group of healthy individuals (controls). - This **retrospective approach** is efficient since it does not require waiting for new cases to develop and allows for the investigation of multiple exposures for a single outcome. *Cross-sectional* - This study design determines the **prevalence** of a disease and exposures at a single point in time. - For rare diseases, a cross-sectional study would likely find very few or no cases, making it **inefficient** for studying disease etiology. *Cohort* - In a cohort study, a group of exposed individuals and a group of unexposed individuals are followed over time to see who develops the disease. - This design is **impractical and expensive** for rare diseases because a very large cohort would be needed to observe a sufficient number of disease cases. *Randomized trial* - Randomized controlled trials are primarily used to assess the **efficacy of interventions** by randomly assigning participants to treatment or control groups. - This design is **not suitable for studying the etiology** of rare diseases or risk factors, as it involves manipulating exposure, which is unethical for potential causes of disease.
Question 5: According to Hill's criteria, which of the following is NOT a criterion for establishing causality in noncommunicable diseases?
- A. Strength of association
- B. Absence of temporal sequence (Correct Answer)
- C. Dose response relationship
- D. Specificity of association
Explanation: ***Absence of temporal sequence*** - A crucial criterion for establishing causality is the **presence of a temporal sequence**, meaning the exposure must precede the outcome. - The **absence of a temporal sequence** would argue directly against causality, as the cause cannot come after the effect. *Strength of association* - This criterion suggests that a **stronger statistical association** between an exposure and an outcome makes a causal relationship more likely. - A large **relative risk** or **odds ratio** indicates a strong association. *Dose response relationship* - This criterion implies that as the **amount or duration of exposure increases**, the **risk or severity of the outcome also increases**. - This **dose-response gradient** strengthens the argument for a causal link. *Specificity of association* - This criterion suggests that a single exposure leads to a **specific effect**, and not a wide range of unrelated effects. - While helpful, **lack of specificity does not rule out causality**, as many exposures can have multiple effects.
Question 6: In which type of study is selection bias most likely to occur?
- A. Cohort study
- B. Case-control study (Correct Answer)
- C. Cross-sectional study
- D. Randomized controlled trial (RCT)
Explanation: ***Case-control study*** - **Selection bias** is a common concern as cases and controls are often selected based on their disease status, making it difficult to ensure they represent the underlying population's exposure distribution. - This study design inherently involves **retrospective data collection**, increasing the risk of differential selection of participants based on their exposure history. - The retrospective nature and non-random selection of cases and controls makes this study type **most vulnerable** to selection bias. *Cohort study* - While selection bias can occur (e.g., participants lost to follow-up), it is generally **less pronounced** than in case-control studies because subjects are selected based on **exposure status** before disease development, minimizing bias related to outcome. - The prospective nature of many cohort studies reduces the risk of selecting participants based on a known outcome. *Cross-sectional study* - Selection bias can occur if the sample is not representative of the target population. - However, since both exposure and outcome are measured **simultaneously**, there is no temporal selection based on outcome status as seen in case-control studies. - The risk is lower than case-control studies as participants are typically selected from a defined population at one point in time. *Randomized controlled trial (RCT)* - **Randomization** is specifically designed to minimize selection bias by ensuring that exposure (intervention) assignment is independent of participant characteristics. - The process of randomly assigning participants to treatment or control groups reduces the likelihood of systemic differences between groups at baseline.
Question 7: The difference between the incidence in the exposed and non-exposed group is best given by:
- A. Attributable risk (Correct Answer)
- B. Population attributable risk
- C. Odds ratio
- D. Relative risk
Explanation: ***Attributable risk*** - **Attributable risk** (AR), also known as risk difference, directly quantifies the absolute difference in disease incidence between an **exposed group** and an **unexposed group**. - It represents the amount of disease incidence (or risk) in the exposed group that is **directly attributable to the exposure**, assuming a causal relationship. *Population attributable risk* - **Population attributable risk** (PAR) measures the proportion of disease incidence in the **total population** that is attributable to the exposure. - It takes into account both the impact of the exposure and the **prevalence of the exposure** in the population, which is distinct from simply comparing exposed and non-exposed groups. *Odds ratio* - The **odds ratio** (OR) is a measure of association between an exposure and an outcome, representing the **odds of an outcome occurring in the exposed group** compared to the odds of it occurring in the unexposed group. - It does not directly express the difference in incidence but rather the **ratio of odds**, often used in case-control studies. *Relative risk* - **Relative risk** (RR), or risk ratio, is the ratio of the **incidence of an outcome in the exposed group** to the incidence in the unexposed group. - It indicates how many times more likely an exposed group is to develop the outcome compared to an unexposed group, expressing a **ratio rather than a difference**.
Question 8: A 10-year long study concerning the use of fluorides and pit and fissure sealants in the control of caries on the same population group is an example of:
- A. Experimental study
- B. Case control study
- C. Prospective cohort study (Correct Answer)
- D. Cross sectional study
Explanation: ***Prospective cohort study*** - This study design involves following a group of individuals (**cohort**) over a period of time (10 years) to observe the development of an outcome (caries control) in relation to specific exposures (fluorides and sealants). - The study starts with individuals free of the outcome and collects data prospectively, making it ideal for studying the **incidence** and **natural history** of diseases or the effectiveness of interventions over time. *Experimental study* - An experimental study, such as a **randomized controlled trial (RCT)**, would involve the active manipulation of an intervention and random assignment of subjects to different groups (e.g., fluoride group vs. no fluoride group). - While interventions are being observed (fluorides, sealants), the description does not mention random assignment or direct researcher manipulation for comparison, only observation over time. *Case control study* - A case-control study is **retrospective**, meaning it starts with an outcome (cases with caries vs. controls without caries) and looks back in time to identify potential exposures. - This study, however, follows the same population group for 10 years to observe outcomes, which is a key characteristic of prospective designs. *Cross sectional study* - A cross-sectional study measures exposures and outcomes at a **single point in time**, providing a snapshot of the population. - This study, lasting 10 years and observing changes over time, clearly goes beyond a single time point and is designed to assess changes and relationships longitudinally.
Question 9: What is the primary purpose of interventional studies in clinical research?
- A. Confirming Hypotheses
- B. Testing Hypotheses (Correct Answer)
- C. Manipulating Hypotheses
- D. Formulating Hypotheses
Explanation: ***Testing Hypotheses*** - Interventional studies, such as **randomized controlled trials**, are specifically designed to **test cause-and-effect relationships** by actively intervening. - They aim to determine if a specific intervention (e.g., a drug, a therapy) produces a hypothesized outcome. *Confirming Hypotheses* - While interventional studies can confirm hypotheses, their primary role is not just confirmation but the initial **rigorous testing** of a hypothesis under controlled conditions. - Confirmation often implies that previous evidence already strongly supports the hypothesis. *Manipulating Hypotheses* - Hypotheses themselves are not "manipulated"; rather, the **variables** within the study design (e.g., treatment groups, dosages) are manipulated to test the hypothesis. - This option incorrectly applies the concept of manipulation to the hypothesis. *Formulating Hypotheses* - Hypothesis formulation usually occurs during the **observational research phase** or through literature review, *before* interventional studies are designed. - Observational studies or descriptive research are more typically used for generating new hypotheses.
Question 10: What is the definition of Population Attributable Risk?
- A. The difference between incidence in population and incidence in exposed.
- B. The difference between incidence in population and incidence in non-exposed. (Correct Answer)
- C. The difference between incidence in population and incidence in non-exposed compared with incidence in exposed.
- D. The difference between incidence in exposed and incidence in non-exposed.
Explanation: ***Correct: The difference between incidence in population and incidence in non-exposed.*** - **Population Attributable Risk (PAR)** quantifies the excess incidence of disease in the total population that is attributable to a specific exposure. - Formula: **PAR = Incidence in total population - Incidence in unexposed** - It represents the amount of disease burden that would be eliminated from the entire population if the exposure were completely removed. - PAR accounts for both the strength of association and the prevalence of exposure in the population. *Incorrect: The difference between incidence in population and incidence in exposed.* - This formula (I(population) - I(exposed)) does not correctly capture PAR. - This calculation does not isolate the portion of disease attributable to the exposure across the entire population. - It fails to provide meaningful information about attributable risk. *Incorrect: The difference between incidence in population and incidence in non-exposed compared with incidence in exposed.* - This option introduces unnecessary complexity and is not the standard definition of PAR. - PAR is a simple difference, not a comparative ratio involving exposed individuals. - This description confuses PAR with other epidemiological measures. *Incorrect: The difference between incidence in exposed and incidence in non-exposed.* - This describes **Attributable Risk (AR)** or **Risk Difference (RD)**, not Population Attributable Risk. - Formula: **AR = I(exposed) - I(unexposed)** - AR measures excess risk in the exposed group only, without considering the prevalence of exposure in the total population. - PAR differs from AR by accounting for how common the exposure is in the population.
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free